![](/img/cover-not-exists.png)
Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
Rischin, D., Bibby, D. C., Chong, G., Kremmidiotis, G., Leske, A. F., Matthews, C. A., Wong, S. S., Rosen, M. A., Desai, J.Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-11-0937
Date:
August, 2011
File:
PDF, 359 KB
english, 2011